Miraculins is an emerging biotechnology company committed to extending life, reducing suffering and lowering healthcare costs.
Through our leadership in the development and commercialization of diagnostic tests, we strive to improve the overall diagnosis and treatment of patients by enhancing the information available to physicians.
Our lead medical device programs are the PreVu Non-Invasive Skin Cholesterol Point-of-Care (POC) Test and the Scout DS Non-Invasive Diabetes Screening Test.